Macrosalb Medi-Radiopharma

Macrosalb, the active ingredient in Macrosalb Medi‑Radiopharma, is a radiopharmaceutical presented as a kit for radiopharmaceutical preparation for intravenous use. It is used to assess lung perfusion and to aid in the diagnosis of pulmonary embolism in adult patients.

GNH USA supplies Macrosalb Medi‑Radiopharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Macrosalb is employed in nuclear medicine imaging of the pulmonary circulation.

- Lung perfusion imaging: provides quantitative assessment of regional blood flow in the lungs. - Ventilation‑perfusion (V/Q) scan: enables combined evaluation of ventilation and perfusion to detect mismatches. - Pulmonary embolism detection: helps identify obstructed pulmonary arteries by revealing perfusion defects.

Macrosalb may be associated with adverse reactions related to the radiopharmaceutical preparation and its intravenous administration.

Common Side Effects: - Injection site pain: mild discomfort at the site of intravenous administration. - Transient flushing: brief sensation of warmth or redness. - Nausea: mild, short‑lasting nausea. - Headache: mild headache occurring shortly after injection.

Serious or Rare Side Effects: - Allergic reaction: urticaria, bronchospasm, or anaphylaxis. - Radiation‑induced tissue injury: rare localized radiation damage. - Hemodynamic changes: hypotension or arrhythmia in susceptible patients.

When using Macrosalb, clinicians should observe specific precautions to ensure patient safety and product integrity.

- Patient assessment: verify indication and contraindications before administration. - Pregnancy status: avoid use unless benefits outweigh potential fetal radiation exposure. - Thyroid protection: consider thyroid blockade in patients at risk of iodine uptake. - Renal function: assess kidney function as radiopharmaceutical clearance may be affected. - Allergies: inquire about known hypersensitivity to albumin or technetium compounds. - Store at ambient temperature: keep kit below 25°C, protect from moisture and light, and use before expiry.

Macrosalb may interact with certain agents that affect radiation distribution or physiological responses.

Major Interactions (Avoid): - Iodine‑containing contrast agents: can interfere with technetium imaging and increase radiation exposure. - Thyroid‑blocking agents (e.g., potassium iodide) administered shortly before: may alter biodistribution.

Moderate Interactions (Monitor Closely): - Vasodilators: may influence pulmonary blood flow and affect imaging interpretation. - Beta‑blockers: could modify heart rate, impacting image acquisition timing. - Antihistamines: may mask early signs of allergic reactions.